ANN ARBOR, Mich., May 27, 2010 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of autologous cellular therapies for the treatment of severe cardiovascular diseases, today announced that Ronnda Bartel, Ph.D., chief scientific officer, will participate in a plenary session at the first annual Stem Cell Investor & Executive Networking Conference Event (SCIENCE). In the session, entitled “Autologous Approaches,” Dr. Bartel will present an update on novel technology for cardiovascular regeneration with cellular therapies produced from a small sample of a patient’s own bone marrow. This plenary session will take place from 2:00 p.m. to 2:45 p.m. To join the conference via webcast, please register at https://www1.gotomeeting.com/register/134153232. If you are unable to join via Internet, please call (800) 882-3610 and enter 2178545 when prompted for a passcode. If you are calling from outside the U.S., please use the international phone number (412) 380-2000.
